Please assess the completion status of the following clinical trial:

Trial Title: Gabapentin Treatment of Cannabis Dependence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males or females age 18-65 with cannabis dependence~* Meets DSM-IV-TR criteria for Cannabis Dependence~* Smoked marijuana at least once a week in the 90 days prior to study participation~* Willing to attend 12 weekly study visits and 1 follow-up visit~Exclusion Criteria:~* Currently meets DSM-IV-TR criteria for dependence on illicit substances other than cannabis~* Significant medical disorders that will increase potential risk or interfere with study participation~* Women with childbearing potential who are pregnant, nursing, or refuse to use a reliable method of birth control~* Treatment with an investigational drug in the last month

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Gabapentin (Type: EXPERIMENTAL): 1200 mg/daily of Gabapentin
- Placebo (Type: PLACEBO_COMPARATOR): 1200mg/d of Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).